Revenio Group Oyj REG1V
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
Trading Information
- Previous Close Price
- €10.50
- Day Range
- €10.38–10.54
- 52-Week Range
- €10.36–25.85
- Bid/Ask
- €10.44 / €10.50
- Shares Outstanding
- 34.75M
- Market Cap
- €361.39M
- Volume/Avg
- 40,970 / 96,189
Key Statistics
- Price/Earnings (Normalized)
- 16.92
- Price/Sales
- 2.69
- Dividend Yield (Trailing)
- 0.00%
- Dividend Yield (Forward)
- 0.00%
- Dividend Payment Schedule
- —
- Total Yield
- —
Company Profile
Revenio Group Oyj is a Finnish health technology company. It develops and commercializes effective, easy-to-use health tech-related screening devices for detecting diseases of public health significance. Its ophthalmic diagnostic solutions include intraocular pressure (IOP) measurement devices (tonometers), and perimeter and fundus imaging devices under the iCare brand. Its eye care software platform, Oculo, offers clinical communication, telehealth, remote patient monitoring, and data analytics capabilities. The company generates the majority of its revenue from the United States.
- Sector
- Healthcare
- Industry
- Medical Devices
- Stock Style Box
- Small Core
- Total Number of Employees
- 765
- Website
- https://www.reveniogroup.fi
Valuation
|
Metric
|
REG1V
|
|---|---|
Price/Earnings (Normalized) | 16.92 |
Price/Book Value | 2.42 |
Price/Sales | 2.69 |
Price/Cash Flow | 19.72 |
Price/Earnings
REG1V
Financial Strength
|
Metric
|
REG1V
|
|---|---|
Quick Ratio | 0.33 |
Current Ratio | 0.58 |
Interest Coverage | — |
Quick Ratio
REG1V
Profitability
|
Metric
|
REG1V
|
|---|---|
Return on Assets (Normalized) | 6.24% |
Return on Equity (Normalized) | 11.01% |
Return on Invested Capital (Normalized) | 10.00% |
Return on Assets
REG1V
Medical Devices Industry Comparables
|
1-Day Chart
|
Name
|
Price
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|---|
| Abbott Laboratories
ABT
| LOCK|>v^?Q@h | LOCK|lR?x | $169B | |||
| Medtronic PLC
MDT
| LOCK|D@K?GBT | LOCK|?YhC | $110B | |||
| Stryker Corp
SYK
| LOCK|YjRfy#<# | LOCK|RC | $106B | |||
| Boston Scientific Corp
BSX
| LOCK|k?%P?$ | LOCK|#d%$ | $62B | |||
| Edwards Lifesciences Corp
EW
| LOCK|gW<b><kd | LOCK|BPC$& | $49B | |||
| DexCom Inc
DXCM
| LOCK|>@&PWCs< | LOCK|b@sL? | $32B | |||
| GE HealthCare Technologies Inc Common Stock
GEHC
| LOCK|<qHv?Dx | LOCK|^^ | $29B | |||
| Koninklijke Philips NV ADR
PHG
| LOCK|@! | LOCK|dM | $23B | |||
| Steris PLC
STE
| LOCK|B@!Kh!! | LOCK|V<?wF | $20B | |||
| Zimmer Biomet Holdings Inc
ZBH
| LOCK|dr>zrH! | LOCK|zn& | $17B |
United States